Merck & Co., Inc.MRKNYSE
LOADING
|||
Operating cash flow minus capital expenditures
| Period | Value | Change |
|---|---|---|
| 2024 | $18.10B | +97.9% |
| 2023 | $9.14B | -37.8% |
| 2022 | $14.71B | +52.2% |
| 2021 | $9.66B | +73.5% |
| 2020 | $5.57B | -44.1% |
| 2019 | $9.97B | +20.0% |
| 2018 | $8.31B | +82.2% |
| 2017 | $4.56B | -48.0% |
| 2016 | $8.76B | -21.3% |
| 2015 | $11.14B | - |